Exclusive: Temasek considers sale of Advanced MedTech, likely valued at about $1 bln – sources
Temasek Holdings is exploring selling Advanced MedTech, multiple sources told Reuters on Monday, after the medical devices firm, fully-owned by the Singaporean state investor, received interest from suitors including buyout funds.
Analysis: Private equity’s swoop on listed European firms runs into rising execution risks
European listed companies have not been this cheap for more than a decade, yet for private equity firms looking to put their cash piles to work, costlier financing and stronger resistance from businesses are complicating dealmaking.
Analysis: Malaysia’s labour abuse allegations a risk to export growth model
Malaysia’s government and companies must address mounting allegations of workplace abuse of migrant labourers who fuel the country’s economy, or face risks to its export-reliant growth model, experts warn.
